Brief Cognitive Behaviour Therapy to Prevent Suicide Reattempts: A Feasibility Study in Swedish Psychiatric Inpatient Care

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKarolinska Institutet

About this trial

The goal of this study is to determine whether Brief Cognitive Behaviour Therapy (BCBT), a four-session psychological treatment aimed at reducing suicide attempts, is acceptable and feasible to deliver during psychiatric inpatient care for adults who have been hospitalised following a suicide attempt or who are at high risk of suicide. The main questions it aims to answer are:

1. Is BCBT acceptable among suicidal psychiatric inpatients, and in what ways can the treatment and its delivery be improved to enhance patient engagement and adherence? 2. Is BCBT feasible from the perspectives of treating clinicians, clinic managers, and other relevant personnel, and what are the key facilitators and barriers to its implementation within routine inpatient psychiatric care in Sweden?

Participants will:

* Receive four structured BCBT therapy sessions delivered during hospitalisation, in addition to usual care * Be contacted for follow-up assessments at 1 and 3 months after completing treatment * Take part in an interview about the participants' experience with the treatment 1 month after completing it

Clinical staff, treating psychologists, and managers will also be interviewed to explore the participants' experiences, as well as barriers and facilitators to implementation. Overall, the findings from this study will inform the design of a future randomised trial to test the effectiveness of BCBT in reducing suicide attempts after discharge from inpatient psychiatric care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

admitted following a suicide attempt within one week of admission or presenting with suicidal ideation with a plan and a prior suicide attempt within the last two years

18 years or older

Disqualifiers

current mania, current acute psychosis, or cognitive impairment

expected inpatient stay shorter than four working days

ongoing or planned electroconvulsive therapy

psychiatric or somatic conditions leading to inability to provide informed consent

Trial design

Design model

Single group

Treatments tested in this trial

  • Brief Cognitive Behaviour Therapy

    Behavioral

    Brief Cognitive Behaviour Therapy to prevent suicide reattempts

Treatment groups

32 Participants
are divided into 1 treatment group
Group A: BCBTExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Treatment completion

Proportion of participants completing 3 or more BCBT sessions

Time frame
Posttreatment assessment performed within two working days after the final treatment session.
2

Treatment satisfaction

Patient-reported treatment satisfaction assessed using the Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item scale, with each item rated on a four-point Likert scale (1-4), giving a total score ranging from 8 to 32, with higher scores indicating greater treatment satisfaction.

Time frame
Posttreatment assessment performed within two working days after the final treatment session.
3

Retention

Proportion of participants completing follow-up assessments at 1 and 3 months

Time frame
1- and 3-month follow-up after the final treatment session

Secondary outcomes

1

Decline rate

Proportion of potentially eligible participants who are approached but decline study participation

Time frame
From first potentially eligible participant approached until recruitment of 20 patients is completed (anticipated duration: 6 months)
2

Recruitment pace

Average monthly recruitment rate

Time frame
From first potentially eligible participant approached until recruitment of 20 patients is completed (anticipated duration: 6 months)
3

Likelihood of treatment component use

Patient-reported likelihood of using each treatment component (safety plan, reasons for living list, hope box, restriction of lethal means, coping cards), rated from 0-10 for each treatment component, with higher scores indicating a higher likelihood of using the component.

Time frame
During the 4-session treatment period (planned for 4 consecutive days), assessed at each session
4

Use and perceived helpfulness of treatment components

Patient-reported extent of use and perceived helpfulness of treatment components (safety plan, reasons for living list, hope box, restriction of lethal means, coping cards) rated with 6 items on a 0-10 scale, with higher scores indicating a higher extent of use and perceived helpfulness of the component.

Time frame
1- and 3-month follow-up after the final treatment session

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Karolinska Institutet

Lead sponsor

Region Stockholm

Collaborator